We hypothesized that the consumption of chia (Salvia hispanica L.) flour (CF) and chia oil (CO) improves metabolic disorders in the liver of Wistar rats (Rattus norvegicus domestica) fed a high-fat and high-fructose (HFHF) diet. The animals were fed a HFHF diet (n = 30) or AIN93-M standard diet (n = 10) for eight weeks. After this period, the animals fed HFHF were divided into three groups (n = 10): HFHF diet, HFHF plus 14.7% of CF, and HFHF plus 4% of CO. Histological and biochemical analyses, gene expression, protein levels related to inflammation, and oxidative stress were evaluated in the liver. The HFHF diet caused lipogenesis, liver steatosis, oxidative stress, and inflammation in the animals. The CF and CO intake increased the liver total antioxidant capacity and superoxide dismutase, decreased nitric oxide levels and liver steatosis. Furthermore, the CF and CO led to the upregulation of Cpt1a and Adipor2, respectively, whereas CF downregulated Srebf1. CO intake decreased blood glucose, triglycerides, and the animals’ body weight. Chia did not show effects on mitigating liver pro-inflammatory status, which it may indicate occurs later. The addition of chia into an unbalanced diet is a good and relevant strategy to reduce liver metabolic disorders caused by the high consumption of fructose and saturated fat.
The transition toward new approach methodologies for toxicity testing has accelerated the development of computational models that utilize transcriptomic data to predict chemical-induced adverse effects. Here, we applied supervised machine learning to gene expression data derived from primary human hepatocytes and rat liver models (in vitro and in vivo) to predict drug-induced hepatic steatosis. We evaluated five machine learning classifiers using microarray data from the Open TG-GATEs database. Among these, support vector machine (SVM) consistently achieved the highest performance, with area under the receiver operating characteristic curve (ROC-AUC) of 0.820 in primary human hepatocytes, 0.975 in the rat in vitro model, and 0.966 in the rat in vivo model. To gain mechanistic insights, we functionally profiled the top-ranked predictive genes. Enrichment analyses revealed strong associations with lipid metabolism, mitochondrial function, insulin signalling, oxidative stress, all biological processes central to steatosis pathogenesis. Key predictive genes such as CYP1A1, PLIN2, and GCK mapped to lipid metabolism networks and liver disease annotations, while others highlighted novel transcriptomics signals. Integration with differentially expressed genes and known steatosis markers highlighted both overlapping and distinct molecular features, suggesting that machine learning models capture biologically relevant signals. These findings demonstrate the potential of machine learning models guided by transcriptomic data to identify early molecular signatures of drug-induced hepatic steatosis. The support vector machine model's strong predictive accuracy across species highlights its promise as a scalable and interpretable tool for chemical risk assessment. As data limitations in human toxicology persist, expanding high-quality transcriptomic resources will be critical to further advance non-animal approaches in regulatory toxicology.
Medicinal plant species are genetically engineered to obtain higher production of biomass and specific secondary metabolites, which can be used in the pharmaceutical industry. The aim of the present study was to evaluate the effect of Pfaffia glomerata (Spreng.) Pedersen tetraploid hydroalcoholic extract on the liver of adult Swiss mice. The extract was prepared from the plant roots and given to the animals by gavage, for 42 days. The experimental groups were treated with water (control), Pfaffia glomerata tetraploid hydroalcoholic extract (100, 200 and 400 mg/kg) and Pfaffia glomerata tetraploid hydroalcoholic extract discontinuously (200 mg/kg). The last group received the extract every 3 days, for 42 days. The oxidative status, mineral dynamics, and cell viability were analysed. The liver weight and the number of viable hepatocytes were reduced, despite the increased cell’s number. Increased levels of malondialdehyde and nitric oxide, and changes in iron, copper, zinc, potassium, manganese and sodium levels were observed. aspartate aminotransferase levels were increased while alanine aminotransferase levels were decreased due to BGEt intake. Our results showed that BGEt induced alterations of oxidative stress biomarkers leading to liver injury, which was associated with a reduction in the number of hepatocytes.